Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)

Kenneth B. Gordon; Yayoi Tada; Milan J. Anadkat; Siew Eng Choon; Boni Elewski; Jonathan N. Barker; Arash Mostaghimi; Kilian Eyerich; Ming Tang; Thomas Haeufel; Christian Thoma; Diamant Thaçi

doi:10.1007/s13555-025-01372-8

Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)

Kenneth B. Gordon, Yayoi Tada, Milan J. Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N. Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi

Research output: Contribution to journal › Comment/debate

Abstract

In

Original language	English
Pages (from-to)	1587-1594
Number of pages	8
Journal	Dermatology and Therapy
Volume	15
Issue number	6
DOIs	https://doi.org/10.1007/s13555-025-01372-8
State	Published - Jun 2025

Access to Document

10.1007/s13555-025-01372-8

Fingerprint

Dive into the research topics of 'Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)'. Together they form a unique fingerprint.

Cite this

Gordon, K. B., Tada, Y., Anadkat, M. J., Choon, S. E., Elewski, B., Barker, J. N., Mostaghimi, A., Eyerich, K., Tang, M., Haeufel, T., Thoma, C., & Thaçi, D. (2025). Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7). Dermatology and Therapy, 15(6), 1587-1594. https://doi.org/10.1007/s13555-025-01372-8

@article{194c3bd20df041bfbdb18907423e5e54,

title = "Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)",

abstract = "In",

author = "Gordon, {Kenneth B.} and Yayoi Tada and Anadkat, {Milan J.} and Choon, {Siew Eng} and Boni Elewski and Barker, {Jonathan N.} and Arash Mostaghimi and Kilian Eyerich and Ming Tang and Thomas Haeufel and Christian Thoma and Diamant Tha{\c c}i",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = jun,

doi = "10.1007/s13555-025-01372-8",

language = "English",

volume = "15",

pages = "1587--1594",

journal = "Dermatology and Therapy",

issn = "2193-8210",

number = "6",

}

Gordon, KB, Tada, Y, Anadkat, MJ, Choon, SE, Elewski, B, Barker, JN, Mostaghimi, A, Eyerich, K, Tang, M, Haeufel, T, Thoma, C & Thaçi, D 2025, 'Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)', Dermatology and Therapy, vol. 15, no. 6, pp. 1587-1594. https://doi.org/10.1007/s13555-025-01372-8

Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7). / Gordon, Kenneth B.; Tada, Yayoi; Anadkat, Milan J. et al.
In: Dermatology and Therapy, Vol. 15, No. 6, 06.2025, p. 1587-1594.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)

AU - Gordon, Kenneth B.

AU - Tada, Yayoi

AU - Anadkat, Milan J.

AU - Choon, Siew Eng

AU - Elewski, Boni

AU - Barker, Jonathan N.

AU - Mostaghimi, Arash

AU - Eyerich, Kilian

AU - Tang, Ming

AU - Haeufel, Thomas

AU - Thoma, Christian

AU - Thaçi, Diamant

PY - 2025/6

Y1 - 2025/6

N2 - In

AB - In

UR - http://www.scopus.com/inward/record.url?scp=105002113324&partnerID=8YFLogxK

U2 - 10.1007/s13555-025-01372-8

DO - 10.1007/s13555-025-01372-8

M3 - Comment/debate

C2 - 40186034

AN - SCOPUS:105002113324

SN - 2193-8210

VL - 15

SP - 1587

EP - 1594

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 6

ER -

Correction to: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (Dermatology and Therapy, (2025), 15, 2, (395-411), 10.1007/s13555-024-01325-7)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this